UT-Southwestern Medical Center: Tumor Mutations May Not Predict Response to Immunotherapy
May 23, 2024
May 23, 2024
DALLAS, Texas, May 23 (TNSres) -- The University of Texas Southwestern Medical Center issued the following news release:
The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern Medical Center researchers reported in a retrospective study. The findings, published in Nature Cancer, upend long-held conventional wisdo . . .
The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern Medical Center researchers reported in a retrospective study. The findings, published in Nature Cancer, upend long-held conventional wisdo . . .